Janssen Demonstrates Commitment to Advancing Science and Innovation in the Treatment of Solid Tumors at ESMO Annual Congress

September 8, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson &Johnson announced today that more than ten data presentations from its lung cancer, bladder cancer and prostate cancer portfolio and pipeline will be featured during the European Society for Medical Oncology (ESMO) Annual Congress 2021 virtual meeting, September 16–21. Further details about these data and the science Janssen is advancing will be made available throughout ESMO via the Janssen Oncology Virtual Newsroom.“With a diverse oncology portfolio and pipeline spanning bladder cancer, lung cancer and prostate cancer, Janssen is transforming the treatment landscape for patients living with solid tumors,” said Kiran Patel, M.D., Vice President, Clinical Development, Solid Tumors, Janssen Research &Development, LLC. “The data to be presented at ESMO represent Janssen’s commitment to push the boundaries of innovation on the path to redefine the treatment landscape for people with cancer.”Key highlights from Janssen-sponsored studies to be presented at ESMO include: Data Featuring RYBREVANT® as a Monotherapy and in Combination with Lazertinib in EGFR-Mutated NSCLC·Mini Oral Presentation: Preliminary results from the Phase 1b CHRYSALIS-2 study examines RYBREVANT® and lazertinib in patients with NSCLC and EGFR exon 19 deletion or L858R mutations (Abstract #1193MO)Mini Oral Presentation: Phase 1 CHRYSALIS study evaluates RYBREVANT&r...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news

Related Links:

The first European consensus on vaccination in patients with MS has been developed by the European Committee for Treatment and Research in Multiple Sclerosis and the European Academy of Neurology.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Source: BMJ Comments - Category: General Medicine Source Type: forums
Deaths among people who have been fully vaccinated remain rare, but older adults and those with compromised immune systems are at much higher risk.
Source: NYT Health - Category: Consumer Health News Authors: Tags: your-feed-science Disease Rates Coronavirus (2019-nCoV) Vaccination and Immunization Cancer Multiple Myeloma Immune System Antibodies Multiple Myeloma Research Foundation Powell, Colin L your-feed-health Source Type: news
The CDC released data on Thursday showing that unvaccinated Americans are 11 times as likely to die of COVID-19 than vaccinated people, and six times as likely to be infected.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
AbstractIntroductionSingle-agent belantamab mafodotin (belamaf; BLENREP) demonstrated deep and durable responses in patients with relapsed/refractory multiple myeloma and  ≥ 3 prior lines of therapy, including an immunomodulatory agent, proteasome inhibitor, and anti-CD38 antibody (DREAMM-2; NCT03525678).MethodsAt the time of this study, STORM Part 2, NCT02336815 (selinexor plus low-dose dexamethasone; sel  + dex) was systematically identified as the only feasible comparator to the DREAMM-2 cohort. Matching-adjusted indirect comparisons (MAIC) evaluated efficacy and safety of belamaf (2.5&nbs...
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
AbstractSecond-line treatment options for patients with relapsed, extensive-stage small cell lung cancer (ES-SCLC) are limited, and even with currently available treatments, prognosis remains poor. Until recently, topotecan (a topoisomerase  I inhibitor) was the only drug approved by the United States (US) Food and Drug Administration (FDA) for the management of ES-SCLC following progression after first-line treatment with etoposide plus a platinum derivative (EP; carboplatin preferred). With the most recent approval of EP plus a prog rammed death ligand 1 (PD-L1) inhibitor, there are now more therapeutic options...
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
ConclusionCiprofol has potential for clinical application for continuous intravenous infusion to maintain sedation for 12  h with the same safety, tolerability and efficacy as propofol.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
ConclusionThe dermatologist density in Bavaria correlates positively with the incidence of malignant melanoma. Despite an increased incidence, mortality was not elevated in the respective administrative regions.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
- CBSSports.com site: media |...
Source: Reuters: Health - Category: Consumer Health News Source Type: news
Colin Powell, the first Black secretary of State and chairman of the Joint Chiefs of Staff, dies of COVID-19 complications after bout with blood cancer.
Source: L.A. Times - Health - Category: Consumer Health News Authors: Source Type: news
More News: Abiraterone Acetate | Actos | Alcoholism | Alimta | Allergy & Immunology | Anemia | Arrhythmia | Bilirubin | Biotechnology | Bladder Cancer | Brain | Brain Cancers | Breast Cancer | Cancer | Cancer & Oncology | Cancer Vaccines | Cardiology | Cardiovascular | Chemistry | Chemotherapy | Child Development | Children | Clinical Trials | Congestive Heart Failure | Constipation | Corticosteroid Therapy | Cough | Dermatitis | Dermatology | Diabetes | Drugs & Pharmacology | Endocrinology | Epilepsy | Epithelial Cancer | Fallopian Tube Cancer | Food and Drug Administration (FDA) | Gastroschisis Repair | Headache | Health Management | Heart | Heart Attack | Heart Disease | Heart Failure | Hematology | Hepatitis | Hepatitis Vaccine | Hormones | Hypertension | Hypothyroidism | Infectious Diseases | Interstitial Lung Disease | Ischemic Stroke | Japan Health | Ketoconazole | Laboratory Medicine | Learning | Legislation | Liver | Lung Cancer | Marketing | Migraine | Myeloma | Neurology | Neuroscience | Non-Small Cell Lung Cancer | Opthalmology | Oral Cancer | Organic | Orthopaedics | Ovarian Cancer | Ovaries | Pain | Pain Management | Peritoneal Cancer | Pharmaceuticals | Pneomococcal Vaccine | Politics | Potassium | Prednisolone | Prednisone | Pregnancy | Pregnancy and Breast Cancer | Profits and Losses | Prostate Cancer | Pulmonary Hypertension | Respiratory Medicine | Science | Skin | Sodium | Stroke | Study | Thyroid | Thyroid Cancer | Toxicology | Universities & Medical Training | Urology & Nephrology | Vaccines | Ventricular Arrhythmia | Veterinary Vaccinations | Warnings